ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Budesonid Sandoz®:Sandoz Pharmaceuticals AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
R01AD05 - BudesonideATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R01 - Nasal Preparations

Varenicline nasal spray used for dry eye disease is classified in S01XA.

R01A - Decongestants and Other Nasal Preparations for Topical Use

This group comprises preparations for local treatment in nasal congestion (e.g. sympathomimetics) or for prophylaxis and treatment of allergic rhinitis (e.g. corticosteroids, cromoglicate preparations). Most of the products are nasal drops, nasal sprays or nasal inhalants. Formulations approved for eye, ear and nose are classified in S03.
See also R01B - Nasal decongestants for systemic use, and
R06 - Antihistamines for systemic use.

The DDDs are based on treatment of both nostrils.

R01AD - Corticosteroids

Combinations of corticosteroids with antiinfectives, sympathomimetics, antihistamines etc. are classified in this group at separate 5th levels by using the 50-series.
Fluticasone propionate is classified in R01AD08.

The DDDs are mainly based on the starting dose in the treatment of rhinitis.

R01AD05 - Budesonide
StärkeAdm.RouteNote
 N 
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home